Daewoong Co., Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 003090.KS | 069620.KS | 000640.KS | 067080.KQ | 054670.KQ | 023910.KQ | |
|---|---|---|---|---|---|---|
| Market cap | 628.45B | 1.18T | 604.34B | 182.93B | 72.84B | 148.76B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | — | — | — | — |
| Price/book | — | — | — | — | — | — |
| Dividend yield | 1.33% | 0.58% | 1.87% | 1.49% | 1.93% | 3.94% |
| 1-year change | −31.03% | −23.38% | −14.99% | −36.66% | −22.95% | −13.31% |
| Today | −0.33% | −0.49% | −0.99% | −1.10% | +0.39% | −0.39% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 003090.KS news ›Daewoong Pharmaceutical Hosts First NABOTA Master Class in Latin America to Accelerate Regional Expansion
PR Newswire UK - NABOTA becomes the first Korean botulinum toxin product approved in Argentina, marking a key milestone in its Latin American expansion - First NMC in Latin America brings together approximately 200 medical professionals…
Daewoong Hosts Nabota Aesthetic Class in Buenos Aires
Businesskorea About 200 Medical Professionals From Six Latin American Countries Joined the Two-Day NMC LATAM 2026 Event Daewoong Highlighted Customized Nabota Techniques as South American Sales Continued Rapid Growth Daewoong…
Daewoong Pharmaceutical Target Price Cut 4.8% on Fexuclue Shift to Direct Sales
Quarterly Operating Profit to Rise 40% but Miss Consensus Fexuclue Inventory Drawdown Weighs on Prescription Drug Sales Nabota Shipments to the U.S. Seen Falling in Fourth Quarter Daewoong Pharmaceutical (069620.KS) is expected to post…
Daewoong eyes 2027 GMP approval for microneedle facility
Business Daewoong eyes 2027 GMP approval for microneedle facility Published : Oct. 14, 2026 - 10:42:44 Daewoong Pharmaceutical is expanding its manufacturing capabilities for microneedle drug patches, aiming to secure Good Manufacturing…
From reducing carbon emissions to bridging the digital divide: Daewoong Pharmaceutical supports digitally underserved communities with refurbished PCs
Daewoong Pharmaceutical donated the office PCs that had reached the end of their replacement cycle in one batch to the Korea National Council on Social Welfare. The donated PCs are equipment that Daewoong Pharmaceutical used for office…
Daewoong Pharmaceutical Builds Microneedle Production System: "Targets GMP Approval Next Year"
Published 14 Oct.2026 09:55(KST) Daewoong Pharmaceutical is building production infrastructure to commercialize microneedle medicines, a next-generation drug delivery technology. The company aims to complete Good Manufacturing Practice…
Daewoong Pharmaceutical Builds Dedicated Microneedle Plant in Korea
Sterile Production Site Set Up at Daewoong Bio's No. 3 Plant in Hwaseong Patches for Semaglutide-Based Obesity and Diabetes Treatments Planned Precision Dispensing, Pressurized Drying and Robotic Transfer to Tighten Quality Control…
Daewoong Bio Introduces Alzheimer's Blood Test 'Lumipulse' at Symposium for Dementia Specialists
Published 12 Oct.2026 10:01(KST) Daewoong Bio is partnering with LabGenomics to expand the domestic market for Lumipulse, a blood-based diagnostic test for Alzheimer's disease. Daewoong Bio said on October 12 that it held the FINE…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
en.sedaily.com3
-
asiae.co.kr1
-
biz.chosun.com1
-
businesskorea.co.kr1
-
koreabiomed.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.